Stay updated on Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page
- Check2 days agoChange DetectedRevision numbers updated from v3.4.3 to v3.5.0. This appears to be a behind-the-scenes site update that doesn't alter study details or user actions.SummaryDifference0.1%

- Check10 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3; no changes to study data or user-facing functionality.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe UI was updated to Revision: v3.4.2 and the obsolete government-funding notice was removed; no study details were changed.SummaryDifference0.5%

- Check46 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and the NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check53 days agoChange DetectedAdded a glossary toggle and a new revision indicator (v3.4.0). Minor wording updates to the QC date label and the No FEAR Act data notice, including removal of the old v3.3.4 reference.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to study details or user-facing features.SummaryDifference0.1%

Stay in the know with updates to Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.